The Scientist

» stem cell trials

Most Recent

image: CIRM Ups Translational Velocity

CIRM Ups Translational Velocity

By | December 21, 2015

California’s stem cell agency unveiled a 5-year plan that includes starting 50 new clinical trials.


image: Heart Strings

Heart Strings

By | May 1, 2015

An animated primer on the harvesting, growth, and administration of cardiac cells to heart attack patients


image: Hearts on Trial

Hearts on Trial

By | May 1, 2015

As researchers conduct the most rigorous human trials of cardiac cell therapies yet attempted, a clear picture of whether these treatments actually work is imminent.


image: Stem Cell Trial for Eye Disease Commences

Stem Cell Trial for Eye Disease Commences

By | September 12, 2014

Researchers at the RIKEN Center for Developmental Biology will treat the first patient in its clinical trial testing an induced pluripotent stem cell-based treatment for age-related macular degeneration.


image: Done with Immunosuppressants

Done with Immunosuppressants

By | July 3, 2014

Adult sickle-cell patients have safely stopped taking their immunosuppressant medication thanks to a new type of blood stem-cell transplant.


image: Geron hESC Trial to Resume?

Geron hESC Trial to Resume?

By | May 27, 2014

Nearly three years after Geron shuttered its stem cell program, BioTime receives funding to relaunch a Phase 1 trial for spinal cord injury.


image: More Evidence of Stem Cell Errors

More Evidence of Stem Cell Errors

By | February 25, 2014

A committee at the University of Düsseldorf finds misconduct in cardiologist Bodo-Eckehard Strauer’s work.  


image: Stem-Cell Clinic Moves to Mexico

Stem-Cell Clinic Moves to Mexico

By | February 1, 2013

A company offering experimental stem-cell treatments will carry out its procedures in Mexico after the FDA warned that it would need approval to operate in the U.S.  


image: Opinion: Regenerating Safely

Opinion: Regenerating Safely

By | January 21, 2013

Patient safety is paramount in regulating new stem cell treatments.

1 Comment

image: BioTime Seeks Geron Stem Cell Assets

BioTime Seeks Geron Stem Cell Assets

By | November 13, 2012

Two former Geron CEOs make a bid for the company’s defunct human embryonic stem cell business.

1 Comment

Popular Now

  1. Genetic Test Solves Royal Mystery
    Notebook Genetic Test Solves Royal Mystery

    Genetic analyses lay to rest conspiracy theories about death of Belgian King Albert I, who lost his life in a rock climbing accident more than 80 years ago.

  2. Investigation Finds Pathologist Guilty of Systemic Misconduct
  3. Bacteria and Humans Have Been Swapping DNA for Millennia
  4. Curious George
    Profile Curious George

    George Church has consistently positioned himself at genomics’ leading edge.